Exact Mass: 568.1594

Exact Mass Matches: 568.1594

Found 24 metabolites which its exact mass value is equals to given mass value 568.1594, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

SN38 glucuronide

(2S,3S,4S,5R,6S)-6-{[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C28H28N2O11 (568.1693)


SN38 glucuronide is a metabolite of irinotecan. Irinotecan is a drug used for the treatment of cancer. Irinotecan prevents DNA from unwinding by inhibition of topoisomerase 1. In chemical terms, it is a semisynthetic analogue of the natural alkaloid camptothecin. Its main use is in colon cancer, in particular, in combination with other chemotherapy agents. This includes the regimen FOLFIRI, which consists of infusional 5-fluorouracil, leucovorin, and irinotecan. Irinotecan received accelerated approval by the U.S. (Wikipedia)

   

Azilsartan medoxomil

(5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 2-ethoxy-1-({4-[2-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylate

C30H24N4O8 (568.1594)


   

Viscutin 2

5,7,3,4-Tetrahydroxyflavan 5-O- (2-caffeoyl-beta-D-xylopyranoside)

C29H28O12 (568.1581)


   

6,8-Dimethoxy-2,3-trans-2-(4-hydroxy-2,3-dimethoxyphenyl)-9-(5-hydroxy-2-methoxyphenyl)-3-hydroxymethyl-2,3-dihydro-7H-1,4-dioxono[2,3-h]chromene-7-one

6,8-Dimethoxy-2,3-trans-2- (4-hydroxy-2,3-dimethoxyphenyl) -9- (5-hydroxy-2-methoxyphenyl) -3-hydroxymethyl-2,3-dihydro-7H-1,4-dioxono [ 2,3-h ] chromene-7-one

C29H28O12 (568.1581)


   

4-O-acetyl-7-O-beta-L-fucopyranosyldiphyllin|4-O-acetylpatentiflorin B

4-O-acetyl-7-O-beta-L-fucopyranosyldiphyllin|4-O-acetylpatentiflorin B

C29H28O12 (568.1581)


   

Antibiotic A 80915A

Antibiotic A 80915A

C29H35Cl3O5 (568.155)


   

2,3-trans-2-(4-hydroxy-2,3-dimethoxyphenyl)-9-(5-hydroxy-2-methoxyphenyl)-2-hydroxymethyl-2,3-dihydro-7H-1,4-dioxino<2,3-h>chromen-7-one

2,3-trans-2-(4-hydroxy-2,3-dimethoxyphenyl)-9-(5-hydroxy-2-methoxyphenyl)-2-hydroxymethyl-2,3-dihydro-7H-1,4-dioxino<2,3-h>chromen-7-one

C29H28O12 (568.1581)


   

helisterculin A

helisterculin A

C29H28O12 (568.1581)


   

Azilsartan medoxomil

Azilsartan medoxomil

C30H24N4O8 (568.1594)


C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers Azilsartan medoxomil (TAK 491) is an orally administered angiotensin II receptor type 1 antagonist with IC50 of 0.62 nM, which used in the treatment of adults with essential hypertension[1][2][3][4].

   

1,1,1-Tris(diphenylphosphino)methane

1,1,1-Tris(diphenylphosphino)methane

C37H31P3 (568.1639)


   

Chimarrhinin, (rel)-

Chimarrhinin, (rel)-

C29H28O12 (568.1581)


A natural product found in Chimarrhis turbinata.

   
   
   

6-{[9-(2h-1,3-benzodioxol-5-yl)-6,7-dimethoxy-1-oxo-3h-naphtho[2,3-c]furan-4-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl acetate

6-{[9-(2h-1,3-benzodioxol-5-yl)-6,7-dimethoxy-1-oxo-3h-naphtho[2,3-c]furan-4-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl acetate

C29H28O12 (568.1581)


   

{3,4,5-trihydroxy-6-[1,4,5-trihydroxy-7-(hydroxymethyl)-9h-xanthen-9-yl]oxan-2-yl}methyl 3-(4-hydroxyphenyl)prop-2-enoate

{3,4,5-trihydroxy-6-[1,4,5-trihydroxy-7-(hydroxymethyl)-9h-xanthen-9-yl]oxan-2-yl}methyl 3-(4-hydroxyphenyl)prop-2-enoate

C29H28O12 (568.1581)


   

(2s,3s,4s,5s,6r)-6-{[9-(2h-1,3-benzodioxol-5-yl)-6,7-dimethoxy-1-oxo-3h-naphtho[2,3-c]furan-4-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl acetate

(2s,3s,4s,5s,6r)-6-{[9-(2h-1,3-benzodioxol-5-yl)-6,7-dimethoxy-1-oxo-3h-naphtho[2,3-c]furan-4-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl acetate

C29H28O12 (568.1581)


   

2-(4-hydroxy-2,3-dimethoxyphenyl)-9-(5-hydroxy-2-methoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-2h,3h-[1,4]dioxino[2,3-h]chromen-7-one

2-(4-hydroxy-2,3-dimethoxyphenyl)-9-(5-hydroxy-2-methoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-2h,3h-[1,4]dioxino[2,3-h]chromen-7-one

C29H28O12 (568.1581)


   

[(2r,3s,4r,5r,6r)-3,4,5-trihydroxy-6-[(9s)-1,4,5-trihydroxy-7-(hydroxymethyl)-9h-xanthen-9-yl]oxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

[(2r,3s,4r,5r,6r)-3,4,5-trihydroxy-6-[(9s)-1,4,5-trihydroxy-7-(hydroxymethyl)-9h-xanthen-9-yl]oxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C29H28O12 (568.1581)


   
   

methyl 3-(3,4-dihydroxyphenyl)-6-(3-{[3-(3,4-dihydroxyphenyl)-1-methoxy-1-oxopropan-2-yl]oxy}-3-oxoprop-1-en-1-yl)-7-hydroxy-8-oxobicyclo[2.2.2]oct-5-ene-2-carboxylate

methyl 3-(3,4-dihydroxyphenyl)-6-(3-{[3-(3,4-dihydroxyphenyl)-1-methoxy-1-oxopropan-2-yl]oxy}-3-oxoprop-1-en-1-yl)-7-hydroxy-8-oxobicyclo[2.2.2]oct-5-ene-2-carboxylate

C29H28O12 (568.1581)


   

2-[2-(3,4-dihydroxyphenyl)-5-[(3,4-dihydroxyphenyl)methyl]-6-oxooxan-2-yl]-4-hydroxyoxolan-3-yl 3,5-dihydroxybenzoate

2-[2-(3,4-dihydroxyphenyl)-5-[(3,4-dihydroxyphenyl)methyl]-6-oxooxan-2-yl]-4-hydroxyoxolan-3-yl 3,5-dihydroxybenzoate

C29H28O12 (568.1581)


   

methyl (1s,2r,3s,4s,7s)-3-(3,4-dihydroxyphenyl)-6-[(1e)-3-{[(2s)-3-(3,4-dihydroxyphenyl)-1-methoxy-1-oxopropan-2-yl]oxy}-3-oxoprop-1-en-1-yl]-7-hydroxy-8-oxobicyclo[2.2.2]oct-5-ene-2-carboxylate

methyl (1s,2r,3s,4s,7s)-3-(3,4-dihydroxyphenyl)-6-[(1e)-3-{[(2s)-3-(3,4-dihydroxyphenyl)-1-methoxy-1-oxopropan-2-yl]oxy}-3-oxoprop-1-en-1-yl]-7-hydroxy-8-oxobicyclo[2.2.2]oct-5-ene-2-carboxylate

C29H28O12 (568.1581)


   

(2r,3r)-2-(4-hydroxy-2,3-dimethoxyphenyl)-9-(5-hydroxy-2-methoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-2h,3h-[1,4]dioxino[2,3-h]chromen-7-one

(2r,3r)-2-(4-hydroxy-2,3-dimethoxyphenyl)-9-(5-hydroxy-2-methoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-2h,3h-[1,4]dioxino[2,3-h]chromen-7-one

C29H28O12 (568.1581)